Author Archives: Santiago Gisler

COPD Patients Unaware of Their Higher Risk for Lung Cancer, Study Shows

Patients with chronic obstructive pulmonary disease (COPD) are unaware of their increased lung cancer risk compared with the general population — attributing their chest symptoms to factors other than potential cancer signs, according to a study. The researchers recommended campaigns to raise awareness about this risk since early lung cancer detection…

Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds

Statins, commonly used to lower blood cholesterol levels, can help chronic obstructive pulmonary disease (COPD) patients by preventing or treating COPD-related comorbidities, and by improving patients’ lung function and exercise capacity, according to a meta-analysis study of existing research data. Results from the meta-analysis, titled “Effectiveness of long-term using…

Ensifentrine Shows Benefit as Add-on Maintenance Therapy in Phase 2 Trial, Verona Pharma Says

Data from a three-day Phase 2 clinical trial offered positive results for nebulized ensifentrine (RPL544) as an add-on treatment for chronic obstructive pulmonary disease (COPD), its developer Verona Pharma announced. Ensifentrine is an inhibitor of phosphodiesterase (PDE) proteins PDE3 and PDE4, which are involved in smooth muscle contraction and immune cell-derived inflammation, respectively.